Disease burden and etiologic distribution of community-acquired pneumonia in adults: Evolving epidemiology in the era of pneumococcal conjugate vaccines

Jung Yeon Heo, Joon-Young Song

Research output: Contribution to journalReview article

Abstract

Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates. With the increasing prevalence of chronic medical conditions, a wide spectrum of healthcare-associated pneumonia could also affect the epidemiology of community-acquired pneumonia. Here, we provide an overview of the epidemiological changes associated with community-acquired pneumonia over the decades since pneumococcal conjugate vaccine introduction.

Original languageEnglish
Pages (from-to)287-300
Number of pages14
JournalInfection and Chemotherapy
Volume50
Issue number4
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Conjugate Vaccines
Pneumococcal Vaccines
Pneumonia
Epidemiology
Population Characteristics
Vaccines
Morbidity
Delivery of Health Care
Mortality
Incidence

Keywords

  • Epidemiology
  • Incidence
  • Mortality
  • Pneumococcal conjugate vaccine
  • Pneumonia

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

@article{4073d09d0201403e8d463abbb922c1b6,
title = "Disease burden and etiologic distribution of community-acquired pneumonia in adults: Evolving epidemiology in the era of pneumococcal conjugate vaccines",
abstract = "Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates. With the increasing prevalence of chronic medical conditions, a wide spectrum of healthcare-associated pneumonia could also affect the epidemiology of community-acquired pneumonia. Here, we provide an overview of the epidemiological changes associated with community-acquired pneumonia over the decades since pneumococcal conjugate vaccine introduction.",
keywords = "Epidemiology, Incidence, Mortality, Pneumococcal conjugate vaccine, Pneumonia",
author = "Heo, {Jung Yeon} and Joon-Young Song",
year = "2018",
month = "12",
day = "1",
doi = "10.3947/ic.2018.50.4.287",
language = "English",
volume = "50",
pages = "287--300",
journal = "Infection and Chemotherapy",
issn = "2093-2340",
publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",
number = "4",

}

TY - JOUR

T1 - Disease burden and etiologic distribution of community-acquired pneumonia in adults

T2 - Evolving epidemiology in the era of pneumococcal conjugate vaccines

AU - Heo, Jung Yeon

AU - Song, Joon-Young

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates. With the increasing prevalence of chronic medical conditions, a wide spectrum of healthcare-associated pneumonia could also affect the epidemiology of community-acquired pneumonia. Here, we provide an overview of the epidemiological changes associated with community-acquired pneumonia over the decades since pneumococcal conjugate vaccine introduction.

AB - Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates. With the increasing prevalence of chronic medical conditions, a wide spectrum of healthcare-associated pneumonia could also affect the epidemiology of community-acquired pneumonia. Here, we provide an overview of the epidemiological changes associated with community-acquired pneumonia over the decades since pneumococcal conjugate vaccine introduction.

KW - Epidemiology

KW - Incidence

KW - Mortality

KW - Pneumococcal conjugate vaccine

KW - Pneumonia

UR - http://www.scopus.com/inward/record.url?scp=85059535469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059535469&partnerID=8YFLogxK

U2 - 10.3947/ic.2018.50.4.287

DO - 10.3947/ic.2018.50.4.287

M3 - Review article

AN - SCOPUS:85059535469

VL - 50

SP - 287

EP - 300

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

SN - 2093-2340

IS - 4

ER -